AMBER MASSE: Open Payments
NPI 1235208687 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 33 payments from 7 companies in 2025. Trend: 2023 $453 · 2024 $575 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $237 |
| AstraZeneca Pharmaceuticals LP | 2 | $156 |
| Lilly USA, LLC | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, QULIPTA, UBRELVY, MOUNJARO, AJOVY, Auvelity, LILETTA.
Industry payments across ID — which companies pay providers there.
